Literature DB >> 3986429

Antagonism of inhibitory amino acids by the steroid derivative RU5135.

M A Simmonds, J P Turner.   

Abstract

The steroid derivative RU5135 has been tested for its ability to antagonize glycine and the gamma-aminobutyric acid (GABA) analogue muscimol on isolated preparations of rat optic nerve and cuneate nucleus, respectively. On the cuneate nucleus, RU5135 antagonized muscimol in a competitive manner with a pA2 value of 8.31. RU5135 shared a common site of action with bicuculline that was separate from the picrotoxin site. On the optic nerve, RU5135 antagonized glycine with a pA2 of 7.67. It shared a common site of action with strychnine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986429      PMCID: PMC1987146          DOI: 10.1111/j.1476-5381.1985.tb16143.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  6 in total

1.  A steroid derivative, R 5135, antagonizes the GABA/benzodiazepine receptor interaction.

Authors:  P Hunt; S Clements-Jewery
Journal:  Neuropharmacology       Date:  1981-04       Impact factor: 5.250

2.  Classification of some GABA antagonists with regard to site of action and potency in slices of rat cuneate nucleus.

Authors:  M A Simmonds
Journal:  Eur J Pharmacol       Date:  1982-06-04       Impact factor: 4.432

3.  Evidence that bicuculline and picrotoxin act at separate sites to antagonize gamma-aminobutyric acid in rat cuneate nucleus.

Authors:  M A Simmonds
Journal:  Neuropharmacology       Date:  1980-01       Impact factor: 5.250

4.  Depolarizing responses to glycine, beta-alanine and muscimol in isolated optic nerve and cuneate nucleus.

Authors:  M A Simmonds
Journal:  Br J Pharmacol       Date:  1983-07       Impact factor: 8.739

5.  Presynaptic actions of gamma-aminobutyric acid and some antagonists in a slice preparation of cuneate nucleus.

Authors:  M A Simmonds
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

6.  Regular and lasting neocortical spiking produced by systemic administration of a steroid derivative in the rat.

Authors:  M S Myslobodsky; O Kofman
Journal:  Neuropharmacology       Date:  1983-02       Impact factor: 5.250

  6 in total
  6 in total

1.  An electrophysiological investigation of the characteristics and function of GABAA receptors on bovine adrenomedullary chromaffin cells.

Authors:  J A Peters; J J Lambert; G A Cottrell
Journal:  Pflugers Arch       Date:  1989-10       Impact factor: 3.657

2.  Cloning and functional expression of a Drosophila gamma-aminobutyric acid receptor.

Authors:  R Chen; D Belelli; J J Lambert; J A Peters; A Reyes; N C Lan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

Review 3.  Advantages of an antagonist: bicuculline and other GABA antagonists.

Authors:  Graham A R Johnston
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

4.  Analysis of γ-aminobutyric acid (GABA) type A receptor subtypes using isosteric and allosteric ligands.

Authors:  Richard W Olsen
Journal:  Neurochem Res       Date:  2014-07-12       Impact factor: 3.996

5.  A novel antagonist, phenylbenzene omega-phosphono-alpha-amino acid, for strychnine-sensitive glycine receptors in the rat spinal cord.

Authors:  T Saitoh; M Ishida; M Maruyama; H Shinozaki
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

6.  Electrophysiological study of SR 42641, a novel aminopyridazine derivative of GABA: antagonist properties and receptor selectivity of GABAA versus GABAB responses.

Authors:  M Desarmenien; E Desaulles; P Feltz; M Hamann
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.